Modern Manual Therapy Blog - Manual Therapy, Videos, Neurodynamics, Podcasts, Research Reviews: Blood Flow Restriction
Showing posts with label Blood Flow Restriction. Show all posts
Showing posts with label Blood Flow Restriction. Show all posts
[RESEARCH] Safety of Blood Flow Restriction Training - themanualtherapist.com


Blood Flow Restriction Training Safety


Background:
Blood flow restriction training (BFRT) is defined as the partial restriction of arterial blood flow into the muscle while venous outflow is occluded during a bout of exercise.

BFRT is used for physical training and performance in healthy individuals, as well as an adjunct to physical rehabilitation in injured individuals.

Current understanding of the physiological mechanisms of BFRT and related performance includes:
  • Acute muscle cell swelling.
  • Increased fiber-type recruitment
  • Decreased myostatin.
  • Decreased atrogenes.
  • Satellite cell proliferation.

With the increasing use of BFRT in clinical populations, Minniti et al. (2020) systematically reviewed the research to assess the potential adverse events associated with BFRT when used clinically in the treatment of patients with musculoskeletal disorders.

RESULTS:
  • 19 studies with 322 pooled participants.
  • 9 studies reported no adverse events.
  • 3 reported rare adverse events, including an upper extremity deep vein thrombosis and rhabdomyolysis.
  • 3 case studies reported common adverse events, including acute muscle pain and acute muscle fatigue.

Individuals exposed to BFRT were not more likely to have an adverse event than individuals exposed to exercise alone.

Adverse Events Overall:
  • Overall (14 of 322).
  • Rare Overall (3 of 322).
  • Rare BFRT (3 of 168).
  • Rare Control Group (0 of 154)
  • Any adverse BFRT (10 of 168).
  • Any adverse control (4 of 154).

CONCLUSIONS:
BFRT appears to be a safe intervention and even more so when used according to evidence-based guidelines and in patients with knee-related musculoskeletal disorders.

Further research is needed to make definitive conclusions about the absolute safety in all patient populations.

WANT RESEARCH SENT TO YOU?
👇🏽👇🏽👇🏽
🔻Rapid Review Membership🔻
  • 3 articles every week
  • Key Points & Main Takeaways
  • Read in less than 5 minutes
  • Sent direct to your inbox
  • Access to full-text
  • Only $1 per week.
SOURCE:
Minniti et al. 2020. AmJ Sprt Med 2020;48(7):1773–1785 DOI: 10.1177/0363546519882652

Want to get Certified in BFR Online? Earn your CertMST with everything you need to get started!


Dalton Urrutia, MSc PT

Dalton is a Physical Therapist from Oregon, currently living and running the performance physiotherapy clinic he founded in London for Grapplers and Strength & Conditioning athletes. Dalton runs the popular instagram account @physicaltherapyresearch, where he posts easy summaries of current and relevant research on health, fitness, and rehab topics. 
Want to learn more or contact him?
Reach out online:
@Grapplersperformance

Learn more online - new online discussion group included!


Want an approach that enhances your existing evaluation and treatment? No commercial model gives you THE answer. You need an approach that blends the modern with the old school. 
  • NEW - Online Discussion Group
  • Live cases
  • webinars
  • lecture
  • Live Q&A
  • over 600 videos - hundreds of techniques and more! 
  • Check out MMT Insiders
Keeping it Eclectic...


In addition to your traditional physical therapy evaluation measures and outcomes, there are some considerations to make when using BFR with a patient. Identifying cardiometabolic risk is a top priority as well as ensuring that you have documented measured vitals at baseline and each subsequent visit. While BFR is very safe, this ensures that you are applying BFR in the most safe and effective manner.


In physical therapy, and in truth any healthcare field, it is important to identify measurement instruments that have high reproducibility; that is to say the data obtain from said instrument can be reliably reproduced with subsequent measurements; and use them in clinical practice.

Despite its widespread use, the reproducibility of Doppler Ultrasound (DUS) results measuring limb occlusion pressure (LOP) for BFR had not been yet been researched until a study by Bezzera de Moralis, et al. was released in 2016 entitled: "Upper limbs total occlusion pressure assessment: Doppler ultrasound reproducibility and determination of predictive variables." In it, the authors concluded that DUS has "good reproducibility".

The news that the use of Doppler Ultrasound has good reproducibility in identifying limb occlusion pressure (LOP) is good news for those of us who use it for blood flow restriction (BFR) training. As part of my continuing education course, The Eclectic Approach: Modern Strength Training, I spend a considerable amount of time educating clinicians and strength coaches that while we want to find LOP to individualize pressures, LOP can change on a number of factors: limb girth, location and width of the BFR band, hydration, time of day, etc. It is nice to see that given the variability in the measurement, Doppler US still holds water as the gold standard.

Of note - while this study exclusively looked at reproducibility in the upper extremity, it is safe to assume that the reproducibility would be similar in the lower extremity. However, further studies are needed to confirm.

The ultimate take home message: score one for the use of Doppler US with BFR training. Continue to use to provide safe and effective BFR training options to your clients and patients!

Kyle Coffey
,





Keeping it Eclectic...



Blood Flow Restriction (BFR) training is popular in the strength and rehabilitation worlds to increase hypertrophy and strength. The most common type of exercise where BFR is used as an adjunct is with low intensity resistance exercise (LIRE). As I have indicated before, this is the most logical use of BFR.

But...the profession of "movement experts" - PTs, chiropractors, strength coaches - is missing the boat and underutilizing BFR with aerobic exercise.

The literature investigating BFR with aerobic exercise is growing. Recently, there is a growing body of scientific knowledge that indicates BFR is also effective at increasing aerobic capacity, A conference abstract presented by Smith, et al. in early 2017 indicated that there were increases in aerobic capacity, 1.5 mile times, and muscle cross-sectional area (CSA) following 3 weeks of BFR walking training in healthy males. This is in addition to the other added benefits of BFR use with exercise - muscle hypertrophy, angiogenesis, increase in post-exercise blood flow, and much more!

From a physiological standpoint, the body can not differentiate between the stress from aerobic or strength training. In some of our populations, when lifting high volumes of weights might be contraindicated, BFR with aerobic exercise would be a perfect starting point.
  • In the rehab world, post-operatively or with the elderly or de-conditioned populations
  • For strength clients, recovery days or with concurrent strength and aerobic training!

And these are just a few examples - get creative and match it to your patient's needs and goals. But one thing is certain...use of BFR training is not just for strengthening - don't miss the aerobic boat!




Check out our full seminar now online! Certification coming soon!




Want an approach that enhances your existing evaluation and treatment? No commercial model gives you THE answer. You need an approach that blends the modern with the old school. Live cases, webinars, lectures, Q&A, hundreds of techniques and more! Check out Modern Manual Therapy!

Keeping it Eclectic...



5 Myths About Blood Flow Restriction (BFR) Training

To continue this blog series on BFR (see Part 1 and Part 2), I will highlight five of the most common questions that I receive from clinicians and my answers.

MYTH #1 - Clinicians must have a certification in order to perform blood flow restriction (BFR) training with clients.

Certifications exist because a patented device or technique is being utilized or taught. A great example of this is the GrastonTM technique and its associated tools. And I get why they would do this from a business standpoint.

But the idea that all clinicians must get a certification in instrument-assisted soft tissue manipulation (IASTM) because one company created a certification program to educate clinicians about their specific technique and how to correctly use their tools is absurd.

There is no difference with blood flow restriction training. Given the proper training that is backed by science and focuses on safety and efficacy, any clinician who wants to deploy the principles of BFR should be able to as long as it is covered by their insurance policy and state practice acts.

MYTH #2 - Clinicians must utilize an FDA-approved device in order to safely apply BFR.

This is by far the biggest bone of contention with the discussion surrounding BFR. Understanding the definitions of listed, cleared, approved, and 510(k) exempt by the FDA for medical devices, and how they apply to the category which BFR bands fall under, helps bring clarity to this statement. Please see here for a more detailed explanation of the definitions by the FDA.

Listing a device is the most basic task required of the manufacturers or distributors of a medical product. Listing is not stringent at all. Essentially, it means that as long as the device meets pre-existing standards for the category which have already been identified as safe, the device is automatically “approved” by the FDA. There is no extra safety or effectiveness process involved with listing a device.
Cleared devices are those new devices identified by the FDA as being “substantially equivalent to another legally marketed device”. They must go through the 510(k) submission process, which requires a manufacturer to notify the FDA of their intent to market at least 90 days in advance. This allows the FDA to determine whether the new device is “equivalent to a device already placed into one of the three classification categories.”

Lastly, approved devices are defined by the FDA as needing a “premarket approval (PMA) prior to marketing” and are generally reserved for high risk devices. Therefore, they must provide “reasonable assurance of the device’s safety and effectiveness” during the initial process. You can search for cleared and approved devices utilizing the 510(k) Premarket Notification database here.

Blood flow restriction devices, regardless of the complexity of the design, are considered by the FDA to be pneumatic tourniquets. The FDA lists pneumatic tourniquets under the “General and Plastic Surgery Device” category, with all devices under this heading considered “Therapeutic Devices” (see FDA Code of Federal Regulation 878.5910 here).

The FDA defines a pneumatic tourniquet as an ““air-powered device consisting of a pressure-regulating unit, connecting tubing, and an inflatable cuff. The cuff is intended to be wrapped around a patient’s limb and inflated to reduce or totally occlude circulation during surgery.” (NOTE: emphasis of underlining is my own). Sounds like a BFR device to me!

In addition, pneumatic tourniquets are classified by the FDA as Class I (general controls) devices. Therefore, the device is exempt from the 510(k) premarket notification procedures discussed above. This means that the device does NOT need FDA review prior to marketing devices. This is because they are considered low risk by the FDA and therefore, do not need to provide “reasonable assurance of safety and effectiveness.” Thus, they only need to be listed with the FDA. It is disingenuous and spreading a false narrative to say anything else.

In fact, as it currently sits right now, any BFR device that is listed with the FDA and not used during general surgery as the definition of pneumatic tourniquet states, is technically being used off-label. This isn't the devil though as healthcare practitioners can utilize devices off-label with proper safeguards if they feel the patient will benefit.

But being considered 510(k) exempt does not mean it is the wild west. Pneumatic tourniquets aimed for medical use are subject to limitations in FDA Code of Federal Regulation 878.9 (see here), which is a good thing! Device manufacturers should make sure that their device:
  • be suitable for their intended use
  • be adequately packaged and properly labeled
  • have establishment registration and device listing forms on file with FDA (my note here: if they plan on marketing as medical device)
  • be manufactured under a quality system (with the exception of a small number of class I devices that are subject only to complaint files and general recordkeeping requirements)

Boiled down - what this means is that as long as a device is not intended for a use different from the “intended use of a legally marketed device in that generic type of device” OR the device is not "modified to operate using a different fundamental scientific technology", it does not need pre-market approval and therefore cannot be considered cleared or approved by the FDA.

Yet, let me be very clear: just like anything else, the onus comes back on the clinician to choose the device they are comfortable with and to deploy proper safeguards like Doppler ultrasound (the industry gold standard for identifying limb occlusion pressure or LOP) and confer with their state practice acts and insurance policy coverage.

SUMMARY - If you search the 510(k) premarket notification database for approved and cleared devices, there are not any FDA approved or cleared devices for blood flow restriction and certainly not for the clinical rehabilitation population. Any BFR device that uses the term "FDA approved" is really only LISTED with the FDA because the category of pneumatic tourniquets, which BFR devices fall under, is 510(k) exempt. Just because this category is exempt does not mean general controls are not or should not be present. Given the ease in listing a device under this category, I suspect it is only a matter of time before we see more devices being listed as pneumatic tourniquets.

MYTH #3 - BFR is not safe for clinical populations and is only for athletes.

The research for the use of blood flow restriction (BFR) training in clinical populations is expanding by the day. And it is very promising! Overall, the literature indicates that while there are some definite contraindications, BFR is safe for use with a wide variety of clients, including post-op, osteoarthtisi, and deconditioned patients.

From a post-surgical perspective, during periods of non-weight bearing, BFR has been shown to be highly effective at reducing atrophy and loss of strength and muscle mass which could helpquicken the transition to full weight-bearing status assuming the post-op protocol allows it.

What I would like to clarify is that while BFR is deemed safe in clinical populations, proper safeguards must be taken, including the use of Doppler Ultrasound to find the limb occlusion pressure (LOP). This will help dramatically reduce the potential risks associated with BFR use, improve patient compliance, and enhance outcomes.

In addition, the intensity at which you utilize BFR between athlete and clinical populations will be different. Clinical populations may add minimal resistance to exercises depending on their phase of rehabilitation, but nothing compared to athletes. See Myth #5 for an expansion on this topic.

MYTH #4 - The higher the pressure utilized with BFR, the greater the effect.

This is absolutely, 100% false! The goal of BFR is to create an optimal anabolic environment, without inducing muscle breakdown as seen with traditional strength training. Higher pressures do not correlate in the research to higher or quicker physiological adaptations - in fact, there is an increased risk with minimal benefit at higher pressure. Therefore, whenever you are in doubt or the client/patient cannot tolerate high pressure, it is more about the consistency of use and time under this anabolic environment that produces results.Think of this as anything else that we prescribe - what is the minimum effective dose (MED)?

Furthermore, a higher pressure increases the risk for injury. Because veins are more superficial than arteries and nerves, a moderate pressure with BFR will restrict venous return but not affect arterial or nerve function.

The same pressure on everyone creates a different stimulus. It may produce the same muscular adaptations but cardiovascular response may be different. BFR pressure should be set individually, where at the very least, the subject’s limb circumference, arterial blood pressures, and cuff design (width and shape) are to be taken into the account. Doppler US is the gold standard to identify limb occlusion pressure, which factors in the above items.

MYTH #5 - I need to utilize a complex exercise prescription when utilizing BFR.

KISS Principle: Kiss it simple, stupid! As stated above, if we know the goal of BFR is create an optimal anabolic environment through disturbance of homeostasis, while limiting muscle breakdown, this is a perfect example of where “less is more”.

When I utilize BFR with my patients, I tend to utilize the non-sexy exercises which we have all grown to hate because they don’t seem to be effective in clinical populations - SLR, bridging, TKE, calf raises, bodyweight squats or lunges. But these low intensity resistance exercises (LIRE) are not higher enough in intensity by themselves to be effective at inducing physiological adaptations.

Remember, we are looking to get a systemic response so adding extra weight or more complex exercises doesn’t increase the response. But with BFR, these "basic" exercises become more effective. Higher reps and sets is the name of the game!

Make sure to check out the Modern Strength Training: Blood Flow Restriction live seminar being held August 5-6, 2017 - register here!


Feel free to contact me with any questions!
Instagram: www.instagram.com/motuspt




Want an approach that enhances your existing evaluation and treatment? No commercial model gives you THE answer. You need an approach that blends the modern with the old school. Live cases, webinars, lectures, Q&A, hundreds of techniques and more! Check out Modern Manual Therapy!

Keeping it Eclectic...





References
  1. Segal NA, et al. Efficacy of Blood Flow Restricted Low-Load Resistance Training in Women with Risk Factors for Symptomatic Knee Osteoarthritis. PMRJ. 2015. 7(4): 376-384.
  2. Ohta H, et al. Low-load resistance muscular training with moderate restriction of blood flow after anterior cruciate ligament reconstruction. Acta Orthop Scand. 2003. 74 (1): 62–68.
  3. Hughes L, et al. Blood flow restriction training in clinical musculoskeletal rehabilitation: a systematic review and meta-analysis. British Journal of Sports Medicine. 2017. 0: 1-11.
  4. Scott BR, et al. Exercise with Blood Flow Restriction: An Updated Evidence-Based Approach for Enhanced Muscular Development. Sports Med. 2015. 45: 313.
  5. Loenneke JP, et al. Low intensity blood flow restriction training: a meta-analysis. European Journal of Applied Physiology. 2012. 112(5): 1849-1859.
  6. Slysz J, et al. The efficacy of blood flow restricted exercise: A systematic review & meta-analysis. Journal of Science & Medicine in Sport. 2016; 19: 669-675.

The Safety of BFR

In the last blog about BFR, I discussed what BFR is and how it works. In this post, let’s chat about the safety of BFR as there are a bunch of myths out there that need to be dispelled.
Like any other intervention we utilize as clinicians, whether it is an actual tool or a technique - blood flow restriction (training) is NOT for everyone. However, when BFR is used with the proper precautions and safety measures, and by trained and experienced clinicians, it is highly effective at augmenting the physiological adaptations to strength training in populations regardless of age or training status. This is even true in clinical and rehabilitation populations!

As with most things in life, we cannot say that there is no risk at all. A study done by Nakajima, et al. in 2006 found that out of 12,642 patients undergoing BFR, the incidence of side effects was as follows: venous thrombus (0.055%), pulmonary embolism (0.008%) and rhabdomyolysis (0.008%). Clearly, a risk is present but much lower than most people think.


Interestingly, there is also no evidence (admittedly, the literature is limited in number on this) that there is any negative CV or vascular response such as damage to vessel tissue. In fact, there are many studies that have shown improved blood flow post-exercise and increased angiogenesis (new blood vessel formation). This may help explain the reduction in systolic and diastolic pressures that is seen in some individuals after the use of BFR. (Cezar, et al. 2016)

The most common reported side effects from user of BFR are typically delayed onset muscle soreness (DOMS), numbness, dizziness, and bruising. Yet, these responses do not typically last long and can be minimized with proper monitoring and application by a clinician.

What should I monitor?
When utilizing BFR, it is important for clinicians to monitor the responses prior to and after use. Luckily, this is much easier than people think!

There are some general signs and symptoms that typically occur with too high of pressure. Higher pressures do not correlate in the research to higher physiological adaptations - in fact, there is an increased risk with minimal benefit at higher pressure (remember, veins are superficial compared to arteries). Therefore, whenever you are in doubt or the client/patient cannot tolerate high pressure, it is more about the consistency of use and time under this anabolic environment that produces results.

If these are reported by the patient, discontinue BFR and check location and pressure of the band before continuing use:
  • Sensation of numbness
  • Pins and needles
  • Uncomfortable tingling
  • Severe discomfort
  • Lightheadness or dizziness

Clinicians can also ask patient or clients to rate their perception of the tightness of the cuff on a scale of 0-10. Along this isn’t enough to determine effectiveness, but it does help modify the treatment as needed (similar to RPE). 7/10 perceived tightness has been shown in the literature to be linked to most effectiveness.

How can I avoid potential problems?
Most importantly, a thorough patient history and examination before use will help identify absolute contraindications to BFR. These include history of DVT, Stage III or greater hypertension, higher class arrhythmias, early post-operative period (few days), and acute sickness or fever.

There are also some relative contraindications to be aware of; the more co-morbidities someone has, the more likely that BFR is contraindicated. These include (list is not all-inclusive): pregnancy, Stage II hypertension or lower, BMI > 30 kg/m2, malignancy, and atrial fibrillation.

Location of the BFR band is important as well. For the upper extremity, the band should be placed proximal to the biceps muscle belly, just under the deltoid tuberosity. For the lower extremity, it should be placed as proximal on the thigh near the gluteal fold as possible.

These are the ONLY places that the cuff should be placed. Some have advocated for the use at the forearms or calf but the arteries and nerves are more superficial in this area which substantially increases the risk of injury. I shouldn’t have to say this but...under no circumstances should belts be placed around the neck!

Why Doppler US is Critical for Safety in Clinical Rehab Populations
In addition, as an objective measure, I strongly advocate for the use of Doppler Ultrasound when using BFR in the clinical and rehabilitation populations. Doppler Ultrasound allows the clinician to individualize the pressures for each client or patient by finding their limb occlusion pressure (LOP). Limb occlusion pressure is minimum amount of pressure that occludes blood flow to the limb. Remember, we want to restrict blood flow, not occlude it! The LOP also takes into account the patient’s limb and vessel characteristics as well as the type of cuff that is being utilized.


Therefore, every time a patient comes in and I am going to use BFR, I retake their LOP for that day or limb. Hydration and other factors can slightly alter LOP so it’s best to recheck and monitor. At the very least, make sure to check for arterial blood flow using manual palpation of the radial or brachial artery in the upper extremity, and the dorsalis pedis or posterior tibial artery in the lower extremity.

Check out this video I made that describes the use of Doppler US with BFR!




Conclusion
BFR is safe and effective for a variety of clinical and rehabilitation populations. Proper safety measures help ensure appropriate use. Utilize Doppler US to find limb occlusion pressure to individualize pressures and be aware of relative and absolute contraindications.

Make sure to check out the Modern Strength Training: Blood Flow Restriction live seminar being held August 5-6, 2017 - register here!


Feel free to contact me with any questions!
Instagram: www.instagram.com/motuspt




Want an approach that enhances your existing evaluation and treatment? No commercial model gives you THE answer. You need an approach that blends the modern with the old school. Live cases, webinars, lectures, Q&A, hundreds of techniques and more! Check out Modern Manual Therapy!

Keeping it Eclectic...





References

  1. Cezar MA, et al. Effects of exercise training with blood flow restriction on blood pressure in medicated hypertensive patients. Motriz. 2016. 22(2): 9-17.
  2. Nakajima T, et al. Use and safety of KAATSU training: Results of a national survey. International Journal of Kaatsu Training Research. 2006. 2: 5-13.
  3. Heitkamp, HC, et al. Training with blood flow restriction mechanisms, gain in strength and safety. The Journal of Sports Medicine and Physical Fitness. 2015; 55(5), 9–15.
  4. Nakajima T. Key Considerations when conducting KAATSU training. Int. J. KAATSU Training Res. 2011; 7: 1-6.
  5. Loenneke JP, et al. Potential Safety Issues with blood flow restriction training. Scand J Med Sci Sports. 2011; 21(4): 510-518.